{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:04:51Z","timestamp":1778501091933,"version":"3.51.4"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,1,31]]},"DOI":"10.1248\/bpb.b24-00715","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:13:51Z","timestamp":1738275231000},"page":"60-64","source":"Crossref","is-referenced-by-count":2,"title":["Longitudinal Trend in Antimicrobial Susceptibility among &lt;i&gt;Haemophilus influenzae&lt;\/i&gt;: A Single-Centre Study in Japan"],"prefix":"10.1248","volume":"48","author":[{"given":"Takeaki","family":"Wajima","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468\u20138503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hara","sequence":"additional","affiliation":[{"name":"Yokohama Rosai Hospital, Yokohama 222\u20130036, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468\u20138503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Shirai","sequence":"additional","affiliation":[{"name":"Yokohama Rosai Hospital, Yokohama 222\u20130036, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei-ichi","family":"Uchiya","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468\u20138503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mikasa K, Aoki N, Aoki Y, Abe S, Iwata S, Ouchi K, Kasahara K, Kadota J, Kishida N, Kobayashi O, Sakata H, Seki M, Tsukada H, Tokue Y, Nakamura-Uchiyama F, Higa F, Maeda K, Yanagihara K, Yoshida K. JAID\/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases\/Japanese Society of Chemotherapy\u2014The JAID\/JSC Guide to Clinical Management of Infectious Disease\/Guideline-preparing Committee Respiratory Infectious Disease WG. <i>J. Infect. Chemother.<\/i>, <b>22<\/b> (Suppl.), S1\u2013S65 (2016).","DOI":"10.1016\/j.jiac.2015.12.019"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ishiwada N, Fujimaki K, Matsumoto T, <i>et al.<\/i> Nationwide surveillance of bacterial pathogens isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2017: general overview of pathogenic antimicrobial susceptibility. <i>J. Infect. Chemother.<\/i>, <b>27<\/b>, 139\u2013150 (2021).","DOI":"10.1016\/j.jiac.2020.11.020"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Potts CC, Rodriguez-Rivera LD, Retchless AC, Buono SA, Chen AT, Marjuki H, Blain AE, Wang X. Antimicrobial Susceptibility Survey of Invasive <i>Haemophilus influenzae<\/i> in the United States in 2016. <i>Microbiol. Spectr.<\/i>, <b>10<\/b>, e0257921 (2022).","DOI":"10.1128\/spectrum.02579-21"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) T\u00f8nnessen R, Garcia I, Debech N, Lindstr\u00f8m JC, Wester AL, Skaare D. Molecular epidemiology and antibiotic resistance profiles of invasive <i>Haemophilus influenzae<\/i> from Norway 2017-2021. <i>Front. Microbiol.<\/i>, <b>13<\/b>, 973257 (2022).","DOI":"10.3389\/fmicb.2022.973257"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tsang RSW, Shuel M, Whyte K, Hoang L, Tyrrell G, Horsman G, Wylie J, Jamieson F, Lefebvre B, Haldane D, Gad RR, German GJ, Needle R. Antibiotic susceptibility and molecular analysis of invasive <i>Haemophilus influenzae<\/i> in Canada, 2007 to 2014. <i>J. Antimicrob. Chemother.<\/i>, <b>72<\/b>, 1314\u20131319 (2017).","DOI":"10.1093\/jac\/dkw565"},{"key":"6","unstructured":"6) World Health Organization. \u201cWHO Bacterial Priority Pathogens List, 2024.\u201d: &lt;https:\/\/www.who.int\/publications\/i\/item\/9789240093461&gt;, accessed 23 October, 2024."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tanaka E, Hara N, Wajima T, Ochiai S, Seyama S, Shirai A, Shibata M, Shiro H, Natsume Y, Noguchi N. Emergence of <i>Haemophilus influenzae<\/i> with low susceptibility to quinolones and persistence in tosufloxacin treatment. <i>J. Glob. Antimicrob. Resist.<\/i>, <b>18<\/b>, 104\u2013108 (2019).","DOI":"10.1016\/j.jgar.2019.01.017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yamada S, Seyama S, Wajima T, Yuzawa Y, Saito M, Tanaka E, Noguchi N. beta-Lactamase-non-producing ampicillin-resistant <i>Haemophilus influenzae<\/i> is acquiring multidrug resistance. <i>J. Infect. Public Health<\/i>, <b>13<\/b>, 497\u2013501 (2020).","DOI":"10.1016\/j.jiph.2019.11.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Gutmann L, Williamson R, Collatz E, Acar JF. Mechanisms of beta-lactam resistance in Haemophilus influenzae. <i>Eur. J. Clin. Microbiol. Infect. Dis.<\/i>, <b>7<\/b>, 610\u2013615 (1988).","DOI":"10.1007\/BF01964237"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in <i>Haemophilus influenzae<\/i>. <i>Clin. Microbiol. Rev.<\/i>, <b>20<\/b>, 368\u2013389 (2007).","DOI":"10.1128\/CMR.00040-06"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, Sunakawa K, Inoue M, Konno M. Association of amino acid substitutions in penicillin-binding protein 3 with \u03b2-lactam resistance in \u03b2-lactamase-negative ampicillin-resistant <i>Haemophilus influenzae<\/i>. <i>Antimicrob. Agents Chemother.<\/i>, <b>45<\/b>, 1693\u20131699 (2001).","DOI":"10.1128\/AAC.45.6.1693-1699.2001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Doern GV, Brueggemann AB, Pierce G, Holley HP Jr, Rauch A. Antibiotic resistance among clinical isolates of <i>Haemophilus influenzae<\/i> in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. <i>Antimicrob. Agents Chemother.<\/i>, <b>41<\/b>, 292\u2013297 (1997).","DOI":"10.1128\/AAC.41.2.292"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hasegawa K, Yamamoto K, Chiba N, Kobayashi R, Nagai K, Jacobs MR, Appelbaum PC, Sunakawa K, Ubukata K. Diversity of ampicillin-resistance genes in <i>Haemophilus influenzae<\/i> in Japan and the United States. <i>Microb. Drug Resist.<\/i>, <b>9<\/b>, 39\u201346 (2003).","DOI":"10.1089\/107662903764736337"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Uda K, Okubo Y, Kinoshita N, Morisaki N, Kasai M, Horikoshi Y, Miyairi I. Nationwide survey of indications for oral antimicrobial prescription for pediatric patients from 2013 to 2016 in Japan. <i>J. Infect. Chemother.<\/i>, <b>25<\/b>, 758\u2013763 (2019).","DOI":"10.1016\/j.jiac.2019.03.004"},{"key":"15","unstructured":"15) The Government of Japan. \u201cNational Action Plan on Antimicrobial Resistance (AMR) 2023\u20132027.\u201d: &lt;https:\/\/www.mhlw.go.jp\/content\/10900000\/001096228.pdf&gt;, accessed 23 October, 2024."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kusama Y, Tsuzuki S, Muraki Y, Koizumi R, Ishikane M, Ohmagari N. The effects of Japan\u2019s National Action Plan on Antimicrobial Resistance on antimicrobial use. <i>Int. J. Infect. Dis.<\/i>, <b>103<\/b>, 154\u2013156 (2021).","DOI":"10.1016\/j.ijid.2020.11.158"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Shiro H, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K. Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of <i>Haemophilus influenzae<\/i> and patients\u2019 background factors. <i>J. Infect. Chemother.<\/i>, <b>21<\/b>, 247\u2013256 (2015).","DOI":"10.1016\/j.jiac.2014.11.012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hara N, Wajima T, Seyama S, Tanaka E, Shirai A, Shibata M, Natsume Y, Shiro H, Noguchi N. Isolation of multidrug-resistant <i>Haemophilus influenzae<\/i> harbouring multiple exogenous genes from a patient diagnosed with acute sinusitis. <i>J. Infect. Chemother.<\/i>, <b>25<\/b>, 385\u2013387 (2019).","DOI":"10.1016\/j.jiac.2018.09.015"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Tanaka E, Wajima T, Hara N, Shirai A, Shibata M, Shiro H, Noguchi N. First outbreak of <i>Haemophilus influenzae<\/i> clone ST422 with low susceptibility to quinolones in paediatric patients in Japan. <i>J. Med. Microbiol.<\/i>, <b>69<\/b>, 239\u2013243 (2020).","DOI":"10.1099\/jmm.0.001154"},{"key":"20","unstructured":"20) CLSI. <i>Performance Standards for Antimicrobial Susceptibility Testing<\/i>, 29th ed. CLSI, Wayne, PA (2019)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Seyama S, Wajima T, Yanagisawa Y, Nakaminami H, Ushio M, Fujii T, Noguchi N. Rise in <i>Haemophilus influenzae<\/i> with reduced quinolone susceptibility and development of a simple screening method. <i>Pediatr. Infect. Dis. J.<\/i>, <b>36<\/b>, 263\u2013266 (2017).","DOI":"10.1097\/INF.0000000000001415"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Meats E, Feil EJ, Stringer S, Cody AJ, Goldstein R, Kroll JS, Popovic T, Spratt BG. Characterization of encapsulated and noncapsulated <i>Haemophilus influenzae<\/i> and determination of phylogenetic relationships by multilocus sequence typing. <i>J. Clin. Microbiol.<\/i>, <b>41<\/b>, 1623\u20131636 (2003).","DOI":"10.1128\/JCM.41.4.1623-1636.2003"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Georgiou M, Munoz R, Roman F, Canton R, Gomez-Lus R, Campos J, De La Campa AG. Ciprofloxacin-resistant <i>Haemophilus influenzae<\/i> strains possess mutations in analogous positions of GyrA and ParC. <i>Antimicrob. Agents Chemother.<\/i>, <b>40<\/b>, 1741\u20131744 (1996).","DOI":"10.1128\/AAC.40.7.1741"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kanda Y. Investigation of the freely available easy-to-use software\u2019 EZR\u2019 for medical statistics. <i>Bone Marrow Transplant.<\/i>, <b>48<\/b>, 452\u2013458 (2013).","DOI":"10.1038\/bmt.2012.244"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ide S, Ishikane M, Aoyagi K, Ono A, Asai Y, Tsuzuki S, Kusama Y, Gu Y, Kodama E, Ohmagari N. Investigation of oral macrolide prescriptions in Japan using a retrospective claims database, 2013\u20132018. <i>PLOS ONE<\/i>, <b>18<\/b>, e0287297 (2023).","DOI":"10.1371\/journal.pone.0287297"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kanda N, Ohbe H, Jo T, Matsui H, Fushimi K, Hatakeyama S, Yasunaga H. Trends in inpatient antimicrobial consumption using days of therapy and days of antibiotic spectrum coverage: A nationwide claims database study in Japan. <i>J. Infect. Chemother.<\/i>, <b>30<\/b>, 228\u2013235 (2024).","DOI":"10.1016\/j.jiac.2023.10.012"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Takeuchi N, Ohkusu M, Hoshino T, Yamamoto S, Segawa S, Murata S, Ishiwada N. Emergence of <i>Haemophilus influenzae<\/i> with low susceptibility to quinolones isolated from pediatric patients in Japan. <i>J. Infect. Chemother.<\/i>, <b>27<\/b>, 1020\u20131026 (2021).","DOI":"10.1016\/j.jiac.2021.02.022"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Carrera-Salinas A, Gonzalez-Diaz A, Calatayud L, Mercado-Maza J, Puig C, Berbel D, Camara J, Tubau F, Grau I, Dominguez MA, Ardanuy C, Marti S. Epidemiology and population structure of <i>Haemophilus influenzae<\/i> causing invasive disease. <i>Microb. Genom.<\/i>, <b>7<\/b>, 000723 (2021).","DOI":"10.1099\/mgen.0.000723"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Giufr\u00e8 M, Cardines R, Marra M, Carollo M, Cerquetti M, Stefanelli P. Antibiotic susceptibility and molecular typing of invasive <i>Haemophilus influenzae<\/i> isolates, with emergence of ciprofloxacin resistance, 2017\u20132021, Italy. <i>Microorganisms<\/i>, <b>11<\/b>, 315 (2023).","DOI":"10.3390\/microorganisms11020315"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Tanaka E, Wajima T, Hirai Y, Nakaminami H, Noguchi N. Dissemination of quinolone low-susceptible <i>Haemophilus influenzae<\/i> ST422 in Tokyo, Japan. <i>J. Infect. Chemother.<\/i>, <b>27<\/b>, 962\u2013966 (2021).","DOI":"10.1016\/j.jiac.2021.02.007"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Hara N, Wajima T, Tanaka E, Noguchi N, Shirai A, Shibata M, Shiro H. Two cases in which tosufloxacin was administered for respiratory infections that may have been caused by <i>Haemophilus influenzae<\/i> less susceptible to quinolone. <i>Iryo Yakugaku<\/i>, <b>46<\/b>, 211\u2013214 (2020).","DOI":"10.5649\/jjphcs.46.211"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Mizoi K, Wajima T, Tanaka E, Nakaminami H, Noguchi N. Comparison of the bactericidal effects of quinolones against low-susceptible <i>Haemophilus influenzae<\/i>. <i>J. Med. Microbiol.<\/i>, <b>70<\/b>, 001376 (2021).","DOI":"10.1099\/jmm.0.001376"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Skaare D, Anthonisen IL, Kahlmeter G, Matuschek E, Natas OB, Steinbakk M, Sundsfjord A, Kristiansen BE. Emergence of clonally related multidrug resistant <i>Haemophilus influenzae<\/i> with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013. <i>Euro Surveill.<\/i>, <b>19<\/b>, 20986 (2014).","DOI":"10.2807\/1560-7917.ES2014.19.49.20986"},{"key":"34","unstructured":"34) Brueggemann AB, Jansen van Rensburg MJ, Shaw D, <i>et al.<\/i> Changes in the incidence of invasive disease due to <i>Streptococcus pneumoniae, Haemophilus influenzae<\/i>, and <i>Neisseria meningitidis<\/i> during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. <i>Lancet Digit. Health<\/i>, <b>3<\/b>, e360\u2013e370 (2021)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Deghmane AE, Taha MK. Changes in invasive <i>Neisseria meningitidis<\/i> and <i>Haemophilus influenzae<\/i>  infections in France during the COVID-19 pandemic. <i>Microorganisms<\/i>, <b>10<\/b>, 907 (2022).","DOI":"10.3390\/microorganisms10050907"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/1\/48_b24-00715\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:29:44Z","timestamp":1738380584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/1\/48_b24-00715\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00715","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"b24-00715"}}